Literature DB >> 30639166

A novel monoallelic gain of function mutation in p110δ causing atypical activated phosphoinositide 3-kinase δ syndrome (APDS-1).

Vassilios Lougaris1, Manuela Baronio2, Daniele Moratto3, Giacomo Tampella2, Luisa Gazzurelli2, Mattia Facchetti4, Baldassarre Martire5, Fabio Cardinale6, Francesco Lanzarotto7, Maria Pia Bondioni8, Vincenzo Villanacci4, Bodo Grimbacher9, Alessandro Plebani2.   

Abstract

This study reports on a novel activating p110δ mutation causing adult-onset hypogammaglobulinemia with lymphopenia without the classical presentation of atypical Activated phosphoinositide 3-kinase δ syndrome (ADPS-1), underlining thus the heterogeneous clinical and immunological presentation of p110δ mutated individuals and offers additional data on the role of p110δ in early and late B cell development in humans.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APDS-1; B cells; Bone marrow; Hypogammaglobulinemia; T cells; p110δ

Year:  2019        PMID: 30639166     DOI: 10.1016/j.clim.2019.01.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

1.  E1021K Homozygous Mutation in PIK3CD Leads to Activated PI3K-Delta Syndrome 1.

Authors:  Yanping Wang; Xuemei Chen; Qiuyun Yang; Wenjing Tang; Yanjun Jia; Lina Zhou; Yunfei An; Zhiyong Zhang; Xuemei Tang; Xiaodong Zhao
Journal:  J Clin Immunol       Date:  2020-01-17       Impact factor: 8.317

Review 2.  Monogenic Adult-Onset Inborn Errors of Immunity.

Authors:  Frederik Staels; Tom Collignon; Albrecht Betrains; Margaux Gerbaux; Mathijs Willemsen; Stephanie Humblet-Baron; Adrian Liston; Steven Vanderschueren; Rik Schrijvers
Journal:  Front Immunol       Date:  2021-11-17       Impact factor: 7.561

Review 3.  Activated PI3Kinase Delta Syndrome-A Multifaceted Disease.

Authors:  Romane Thouenon; Nidia Moreno-Corona; Lucie Poggi; Anne Durandy; Sven Kracker
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.